Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by wasagastaron Jul 05, 2017 9:00pm

102 Views

Post# 26437606

RE:RE:RE:RE:Adverse events ... The day BionicJoke looked goofy ... again

bionicjoe, nothing can deny one glaring fact. You are simply a goof with a paid agenda. Tell your boss to pay you $10 for every post today. Hopefully he pays you cash for such cheap work, would'nt want to see you taxed on top of that. I wish you well. GL

bionicjoe wrote:

bencro wrote: BionicClown working hard to do some catch-up, to not look too much of a fool and of a hypocrite paid basher and manipulator.

So lolll.

These videos have debunked all the issues of whiners and paid bashers.

This trial is proceeding extremely well. PDC doesn't enter the blood stream, when compared to the quantity in urine and that's one very good data that looks very good for the high dose patients as it will limit side-effects. Watch @18:46+

https://youtu.be/3P_Pvq1kzVc

Bencro, you couldn't convince the market with your efficacy schtick of knocking those nasty visible tumors dead in a couple of hours so what makes you think you'll have any better luck pushing the safety & tolerability angle on investors which most shareholders have little interest in?